Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prophylactic colchicine for familial Mediterranean fever: response rates revisited.

Scandinavian journal of rheumatology - 1 Sept 2025

Wiener A, Shinar Y, Pras E

Abstract excerpt

OBJECTIVE: Complete response to colchicine is reported in 60-65% of patients with familial Mediterranean fever (FMF), partial response in 30-35%, and poor response in 5-10% of patients. The objective of our study was to revisit colchicine response rates for the common FMF gene (MEFV) genotypes in view of newly available treatments. METHOD: Data were retrieved from medical files of 106 consecutive FMF patients,...

Topics

Join the communities discussing this publication.

Colchicine
Cytoskeletal Proteins
Familial Mediterranean Fever
Homozygote
Pyrin
Treatment Outcome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Tubulin Modulators

Source

Identifiers

PMID: 40468897
DOI: 10.1080/03009742.2025.2478714

Genes

MEFV

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prophylactic colchicine for familial Mediterranean fever: response rates revisited.PMID 40468897Read ↗

A survey of resistance to colchicine treatment for French patients with familial Mediterranean fever.Semantic proximity Read ↗

Can colchicine response be predicted in familial Mediterranean fever patients?Semantic proximity Read ↗

The expanded clinical profile and the efficacy of colchicine therapy in Egyptian children suffering from familial Mediterranean fever: a descriptive study.Semantic proximity Read ↗

Early predictors of colchicine resistance in familial Mediterranean fever.Semantic proximity Read ↗

Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization.Semantic proximity Read ↗

Genotype-Phenotype Associations of Children With Familial Mediterranean Fever in a Cohort Consisting of M694V Mutation and Implications for Colchicine-Resistant Disease.Semantic proximity Read ↗

Unresponsiveness to colchicine therapy in patients with familial Mediterranean fever homozygous for the M694V mutation.Semantic proximity Read ↗

Clinical, genetic, and therapeutic differences in pediatric versus adult colchicine-resistant FMF patients.Semantic proximity Read ↗

Genotype Mutations in Egyptian Children with Familial Mediterranean Fever: Clinical Profile, and Response to ColchicineSemantic proximity Read ↗

Familial Mediterranean fever, from pathogenesis to treatment: a contemporary reviewSemantic proximity Read ↗

Familial mediterranean fever: a fascinating model of inherited autoinflammatory disorder.Semantic proximity Read ↗

Familial Mediterranean fever (FMF) phenotype in patients homozygous to the MEFV M694V mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.